Rea Mittal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rea Mittal has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Ashutosh Kumar
Department of Pediatrics and Neurology, Penn State College of Medicine, Hershey, PA, USA
3 shared publicationsGayatra Mainali
Department of Pediatrics and Neurology, Penn State College of Medicine, Hershey, PA, USA
3 shared publicationsRahul Jain
Indiana University School of Medicine Indianapolis IN 46202 USA
3 shared publicationsRohit Jain
Department of Internal Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania
3 shared publicationsErik Lehman
Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA
2 shared publicationsLilly Su
School of Medicine, Pennsylvania State College of Medicine, Hershey, Pennsylvania
2 shared publications
Latest Publications
- 12 November 2025
- Published by Wiley in AEM Education and Training
- Vol. 9 (6) , e70097
Enhancing Knowledge and Skills in Pediatric Neurologic Emergencies: A Simulation‐Based Medical Education Program for Emergency Medicine Trainees India
Background: India has one of the largest pediatric populations globally, with one in five children affected by a neurological condition. However, access to specialized pediatric neurology care is limited due to a shortage of trained pediatric neurologists. Most pediatric neurology cases are managed by emergency medicine (EM) physicians, adult neurologists, or pediatricians. Strengthening EM physicians' ability to recognize and manage these conditions is critical. Simulation‐based medical education (SBME) offers an effective avenue to enhance knowledge, procedural skills, and self‐efficacy. Methods: The Ronald Reagan Institute of Emergency Medicine at George Washington University has partner programs across India to deliver postgraduate EM training programs. In October 2024, a 2‐week, in‐person pediatric neurology SBME training was conducted across eight partner sites. Faculty included three visiting specialists in pediatric EM and EM, one pediatric neurology resident, and local EM faculty. Training included a didactic session on pediatric neurological emergencies, a procedural workshop, and simulation cases in pediatric neurology emergencies. The structured procedural workshops used pre‐existing checklists to achieve mastery learning in pediatric skills: Intravenous access, intraosseous access, bag‐valve‐mask ventilation, intubation, and lumbar puncture. Trainees completed three pediatric neurology simulation clinical cases, including procedural skills. Pre‐ and posttests, including a 3‐month follow‐up knowledge test and survey, were used to evaluate the effectiveness of the educational intervention. Results: A total of 106 EM trainees from eight sites across India participated in the study with matched pre‐ and postintervention data. Statistically significant improvements were observed across all domains: Medical knowledge, self‐efficacy in procedural skills, and managing pediatric neurologic emergencies. Conclusions: The findings of this study suggest that SBME can enhance EM trainees' self‐efficacy, knowledge, and procedural skills in managing pediatric neurological emergencies. The training model is scalable, adaptable, and effective in resource‐variable environments.
- 12 November 2025
- Published by Wiley in AEM Education and Training
- Vol. 9 (6) , e70097
Enhancing Knowledge and Skills in Pediatric Neurologic Emergencies: A Simulation‐Based Medical Education Program for Emergency Medicine Trainees India
Background: India has one of the largest pediatric populations globally, with one in five children affected by a neurological condition. However, access to specialized pediatric neurology care is limited due to a shortage of trained pediatric neurologists. Most pediatric neurology cases are managed by emergency medicine (EM) physicians, adult neurologists, or pediatricians. Strengthening EM physicians' ability to recognize and manage these conditions is critical. Simulation‐based medical education (SBME) offers an effective avenue to enhance knowledge, procedural skills, and self‐efficacy. Methods: The Ronald Reagan Institute of Emergency Medicine at George Washington University has partner programs across India to deliver postgraduate EM training programs. In October 2024, a 2‐week, in‐person pediatric neurology SBME training was conducted across eight partner sites. Faculty included three visiting specialists in pediatric EM and EM, one pediatric neurology resident, and local EM faculty. Training included a didactic session on pediatric neurological emergencies, a procedural workshop, and simulation cases in pediatric neurology emergencies. The structured procedural workshops used pre‐existing checklists to achieve mastery learning in pediatric skills: Intravenous access, intraosseous access, bag‐valve‐mask ventilation, intubation, and lumbar puncture. Trainees completed three pediatric neurology simulation clinical cases, including procedural skills. Pre‐ and posttests, including a 3‐month follow‐up knowledge test and survey, were used to evaluate the effectiveness of the educational intervention. Results: A total of 106 EM trainees from eight sites across India participated in the study with matched pre‐ and postintervention data. Statistically significant improvements were observed across all domains: Medical knowledge, self‐efficacy in procedural skills, and managing pediatric neurologic emergencies. Conclusions: The findings of this study suggest that SBME can enhance EM trainees' self‐efficacy, knowledge, and procedural skills in managing pediatric neurological emergencies. The training model is scalable, adaptable, and effective in resource‐variable environments.
- Open Access
- 1 May 2023
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 38 (6-7) , 367-372
Use of Complementary and Alternative Medicine in Children with Neuromuscular Disorders Followed at Penn State Health Pediatric Muscular Dystrophy Association Care Center Clinic
The exact prevalence of complementary and alternative medicine (CAM) use is not known in pediatric patients with neuromuscular diseases followed by any of the 150 Muscular Dystrophy Association (MDA) Care Center Clinics nationwide. This study describes the prevalence and variety of CAM usage in this population, while also assessing the prevalence of caregiver disclosure of CAM use and caregiver perception of provider support for CAM. Fifty-two caregivers of pediatric patients seen at Penn State Health's Pediatric MDA Care Center Clinic completed our online survey. Overall, 19.2% of caregivers reported CAM use by their child. Less than half of caregivers reported discussing CAM use with their child's neurologist (41.5%); however, a majority of respondents reported interest in using CAM for their child in the future (52.8%). Understanding the prevalence of CAM usage and disclosure in pediatric MDA clinics may facilitate safer use of CAM in this community.
- 1 May 2023
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 38 (6-7) , 367-372
Open AccessUse of Complementary and Alternative Medicine in Children with Neuromuscular Disorders Followed at Penn State Health Pediatric Muscular Dystrophy Association Care Center Clinic
The exact prevalence of complementary and alternative medicine (CAM) use is not known in pediatric patients with neuromuscular diseases followed by any of the 150 Muscular Dystrophy Association (MDA) Care Center Clinics nationwide. This study describes the prevalence and variety of CAM usage in this population, while also assessing the prevalence of caregiver disclosure of CAM use and caregiver perception of provider support for CAM. Fifty-two caregivers of pediatric patients seen at Penn State Health's Pediatric MDA Care Center Clinic completed our online survey. Overall, 19.2% of caregivers reported CAM use by their child. Less than half of caregivers reported discussing CAM use with their child's neurologist (41.5%); however, a majority of respondents reported interest in using CAM for their child in the future (52.8%). Understanding the prevalence of CAM usage and disclosure in pediatric MDA clinics may facilitate safer use of CAM in this community.
- Open Access
Use of Integrative, Complementary, and Alternative Medicine in Children with Epilepsy: A Global Scoping Review
(1) Background: Epilepsy is one of the most common chronic neurological disorders in childhood. Complementary and alternative medicine (CAM) use is highly prevalent in patients with epilepsy. Despite CAM’s widespread and increasing popularity, its prevalence, forms, perceived benefits, and potential risks in pediatric epilepsy are rarely explored. (2) Methods: We performed a scoping review of the available literature on the use of CAM in pediatric epilepsy. (3) Results: Overall, global cross-sectional studies showed a variable degree of CAM usage among children with epilepsy, ranging from 13 to 44% in prevalence. Popular types of CAMs reported were supplements, cannabis products, aromatherapy, herbal remedies, dietary therapy, massage therapy, and prayer. Families often report that CAM is effective, although there are limited objective measures of this. Potential risks lie in the use of CAM, such as herbal remedies, and/or unregulated, contaminated, or unpurified products. Studies also underscored inadequate patient–physician discussions regarding CAM. (4) Conclusions: A better understanding of this topic would aid clinicians in guiding patients/families on the use of CAM. Further studies on the efficacy of the different types of CAM used, as well as potential side effects and drug interactions are needed.
Open AccessUse of Integrative, Complementary, and Alternative Medicine in Children with Epilepsy: A Global Scoping Review
(1) Background: Epilepsy is one of the most common chronic neurological disorders in childhood. Complementary and alternative medicine (CAM) use is highly prevalent in patients with epilepsy. Despite CAM’s widespread and increasing popularity, its prevalence, forms, perceived benefits, and potential risks in pediatric epilepsy are rarely explored. (2) Methods: We performed a scoping review of the available literature on the use of CAM in pediatric epilepsy. (3) Results: Overall, global cross-sectional studies showed a variable degree of CAM usage among children with epilepsy, ranging from 13 to 44% in prevalence. Popular types of CAMs reported were supplements, cannabis products, aromatherapy, herbal remedies, dietary therapy, massage therapy, and prayer. Families often report that CAM is effective, although there are limited objective measures of this. Potential risks lie in the use of CAM, such as herbal remedies, and/or unregulated, contaminated, or unpurified products. Studies also underscored inadequate patient–physician discussions regarding CAM. (4) Conclusions: A better understanding of this topic would aid clinicians in guiding patients/families on the use of CAM. Further studies on the efficacy of the different types of CAM used, as well as potential side effects and drug interactions are needed.
- 20 December 2022
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 24 (6) , 44747
Neuropsychiatric Manifestations of Mpox (monkeypox) Virus Amidst a Global Outbreak
This report investigates the neuropsychiatric manifestations of mpox infection that providers may encounter in the setting of an mpox virus outbreak.
- 20 December 2022
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 24 (6) , 44747
Neuropsychiatric Manifestations of Mpox (monkeypox) Virus Amidst a Global Outbreak
This report investigates the neuropsychiatric manifestations of mpox infection that providers may encounter in the setting of an mpox virus outbreak.
- 23 May 2022
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 35 (4) , 480-484
A concerning trend in geriatric pharmacy that merits evidence-based intervention
The effects of polypharmacy on geriatric populations are an emerging concern that merits more exploration. The primary goal of this review was to evaluate the current body of knowledge on polypharmacy and explore the preventive and corrective measures to avoid negative outcomes. Even if a medication has an appropriate indication, polypharmacy in the geriatric population is associated with an increased risk of drug-drug or drug-condition interactions. Recent efforts to prevent polypharmacy include the development of interprofessional teams in clinics dedicated to medication review and reconciliation, deprescription plans aimed to safely discontinue potentially inappropriate medications, and inpatient screening tools that provide prescribing recommendations. In conclusion, polypharmacy affects a high percentage of the geriatric population. Current efforts to address and prevent polypharmacy are ongoing but have not been widely adopted.
- 23 May 2022
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 35 (4) , 480-484
A concerning trend in geriatric pharmacy that merits evidence-based intervention
The effects of polypharmacy on geriatric populations are an emerging concern that merits more exploration. The primary goal of this review was to evaluate the current body of knowledge on polypharmacy and explore the preventive and corrective measures to avoid negative outcomes. Even if a medication has an appropriate indication, polypharmacy in the geriatric population is associated with an increased risk of drug-drug or drug-condition interactions. Recent efforts to prevent polypharmacy include the development of interprofessional teams in clinics dedicated to medication review and reconciliation, deprescription plans aimed to safely discontinue potentially inappropriate medications, and inpatient screening tools that provide prescribing recommendations. In conclusion, polypharmacy affects a high percentage of the geriatric population. Current efforts to address and prevent polypharmacy are ongoing but have not been widely adopted.
- Open Access
- 25 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22605
Acute Calcific Cerebral Embolism Large Vessel Occlusion: A Unique Stroke Mechanism With Hard Challenges
We present the case of an ischemic stroke associated with partially occlusive acute calcified cerebral emboli large vessel occlusion (CCE LVO). No revascularization strategy guidelines have been established for this unique acute ischemic stroke population, although many studies have reported impaired and inconsistent responses to both thrombolysis and thrombectomy. The patient in this case report, unfortunately, experienced a failed attempt at complete thrombolysis, resulting in a poor clinical outcome. Endovascular thrombectomy was not performed because of incomplete obstruction and risk of injury. Follow-up imaging revealed an acute ischemic stroke at the large middle cerebral artery and a new intraparenchymal hemorrhage with complete absence of the previously identified calcified embolus. This case and current literature demonstrate that more data are needed to determine the best revascularization approach for patients with CCE LVO stroke. With tissue plasminogen activator marginally effective in these patients, thrombectomy should be considered in highly unstable, clinically symptomatic patients even only with partial vessel occlusion.
- 25 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22605
Open AccessAcute Calcific Cerebral Embolism Large Vessel Occlusion: A Unique Stroke Mechanism With Hard Challenges
We present the case of an ischemic stroke associated with partially occlusive acute calcified cerebral emboli large vessel occlusion (CCE LVO). No revascularization strategy guidelines have been established for this unique acute ischemic stroke population, although many studies have reported impaired and inconsistent responses to both thrombolysis and thrombectomy. The patient in this case report, unfortunately, experienced a failed attempt at complete thrombolysis, resulting in a poor clinical outcome. Endovascular thrombectomy was not performed because of incomplete obstruction and risk of injury. Follow-up imaging revealed an acute ischemic stroke at the large middle cerebral artery and a new intraparenchymal hemorrhage with complete absence of the previously identified calcified embolus. This case and current literature demonstrate that more data are needed to determine the best revascularization approach for patients with CCE LVO stroke. With tissue plasminogen activator marginally effective in these patients, thrombectomy should be considered in highly unstable, clinically symptomatic patients even only with partial vessel occlusion.
- 24 February 2022
- Published by Taylor & Francis in Future Cardiology
- Vol. 18 (4) , 337-343
Peripartum Cardiomyopathy: A Review of Current Literature
Peripartum cardiomyopathy (PPCM) is systolic heart failure in a woman who is pregnant or in the early postpartum period. There are multiple theories regarding the pathophysiology of this disease, a... Plain language summary Peripartum cardiomyopathy is a heart disorder that involves decreased blood flow from the aorta to the rest of the body. This can occur during pregnancy, or shortly thereafte...
- 24 February 2022
- Published by Taylor & Francis in Future Cardiology
- Vol. 18 (4) , 337-343
Peripartum Cardiomyopathy: A Review of Current Literature
Peripartum cardiomyopathy (PPCM) is systolic heart failure in a woman who is pregnant or in the early postpartum period. There are multiple theories regarding the pathophysiology of this disease, a... Plain language summary Peripartum cardiomyopathy is a heart disorder that involves decreased blood flow from the aorta to the rest of the body. This can occur during pregnancy, or shortly thereafte...
- 31 January 2022
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 37 (5) , 334-339
Complementary and Alternative Medicine (CAM) use in Children with Epilepsy
Complementary and alternative medicine (CAM) use by the pediatric population with epilepsy in rural Pennsylvania was studied to characterize the prevalence, perceived effectiveness, and reasons for CAM use. This study additionally assessed the adequacy of parent-physician communication regarding CAM usage. A telephone survey was administered to 200 parents/caregivers of children with epilepsy followed at Hershey Medical Center. Thirteen percent of respondents indicated CAM use by their child. Common types of CAM used were cannabis-related products such as CBD oil and medical marijuana. Forty-eight percent of CAM users chose to initiate CAM owing to dissatisfaction with the outcomes of antiseizure drugs. Fifty-nine percent noticed a decrease in seizure frequency with CAM use, and more than 11% of CAM users reported side effects from CAM. Eighty percent of CAM users had discussions regarding CAM with their child's neurologist. CAM use was found to be associated with increased seizure severity ( P = .004) and the prior use of cannabidiol (Epidiolex) ( P < .001) or the ketogenic diet ( P = .001). Increased seizure severity and the prior use of Epidiolex or the ketogenic diet may be used as predictors for the identification of patients with a higher likelihood of using CAM. Interest in future CAM use, especially cannabis-related products, was expressed in a large percentage of non-CAM users. Given the high parental or caregiver interest in CAM, providers are encouraged to be proactive in initiating discussions about CAM and collaborate with parents/caregivers to ensure the safe usage of CAM among pediatric patients.
- 31 January 2022
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 37 (5) , 334-339
Complementary and Alternative Medicine (CAM) use in Children with Epilepsy
Complementary and alternative medicine (CAM) use by the pediatric population with epilepsy in rural Pennsylvania was studied to characterize the prevalence, perceived effectiveness, and reasons for CAM use. This study additionally assessed the adequacy of parent-physician communication regarding CAM usage. A telephone survey was administered to 200 parents/caregivers of children with epilepsy followed at Hershey Medical Center. Thirteen percent of respondents indicated CAM use by their child. Common types of CAM used were cannabis-related products such as CBD oil and medical marijuana. Forty-eight percent of CAM users chose to initiate CAM owing to dissatisfaction with the outcomes of antiseizure drugs. Fifty-nine percent noticed a decrease in seizure frequency with CAM use, and more than 11% of CAM users reported side effects from CAM. Eighty percent of CAM users had discussions regarding CAM with their child's neurologist. CAM use was found to be associated with increased seizure severity ( P = .004) and the prior use of cannabidiol (Epidiolex) ( P < .001) or the ketogenic diet ( P = .001). Increased seizure severity and the prior use of Epidiolex or the ketogenic diet may be used as predictors for the identification of patients with a higher likelihood of using CAM. Interest in future CAM use, especially cannabis-related products, was expressed in a large percentage of non-CAM users. Given the high parental or caregiver interest in CAM, providers are encouraged to be proactive in initiating discussions about CAM and collaborate with parents/caregivers to ensure the safe usage of CAM among pediatric patients.
- Open Access
- 31 July 2021
- Published by Wiley in Journal of Lipids
- Vol. 2021, 1-5
Current Management Guidelines on Hyperlipidemia: The Silent Killer
Given the high incidence of cardiovascular events in the United States, strict control of modifiable risk factors is important. Pharmacotherapy is helpful in maintaining control of modifiable risk factors such as elevated lipids or hypercholesterolemia. Hypercholesterolemia can lead to atherosclerotic disease which may increase the risk of acute coronary events. Statin therapy has long been a mainstay in the treatment of hypercholesterolemia, but while highly regarded, statin therapy also has side effects that may lead to patient noncompliance. Therefore, various medicines are being developed to manage hypercholesterolemia. This paper will discuss the role that lipids play in the pathophysiology of atherosclerotic disease, review the current lipid management guidelines, and discuss new treatment options that are alternatives to statin therapy.
- 31 July 2021
- Published by Wiley in Journal of Lipids
- Vol. 2021, 1-5
Open AccessCurrent Management Guidelines on Hyperlipidemia: The Silent Killer
Given the high incidence of cardiovascular events in the United States, strict control of modifiable risk factors is important. Pharmacotherapy is helpful in maintaining control of modifiable risk factors such as elevated lipids or hypercholesterolemia. Hypercholesterolemia can lead to atherosclerotic disease which may increase the risk of acute coronary events. Statin therapy has long been a mainstay in the treatment of hypercholesterolemia, but while highly regarded, statin therapy also has side effects that may lead to patient noncompliance. Therefore, various medicines are being developed to manage hypercholesterolemia. This paper will discuss the role that lipids play in the pathophysiology of atherosclerotic disease, review the current lipid management guidelines, and discuss new treatment options that are alternatives to statin therapy.
- Open Access
- 22 June 2021
- Published by Springer Nature in Cureus
- Vol. 13 (6) , e15825
Re-Positive SARS-CoV-2 With Respiratory Failure and Cerebrovascular Accident: Is This a Reinfection?
The coronavirus disease 2019 ( COVID-19) pandemic is a global pandemic where healthcare providers are concerned about the reinfection of recovered patients. The reinfection with COVID-19 is not common and considered less likely, but as time passes by, there are reports of patients becoming positive after having tested negative previously. Here, we report a case of a 28-year-old male with diabetes mellitus type 1, hypertension, and end-stage renal disease on hemodialysis who presented initially in April 2020 with nausea, vomiting, and dyspnea. His severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) came back positive. He left against medical advice but was followed as an outpatient in the dialysis unit where he continued with dialysis in isolation for positive COVID-19 as per the dialysis unit guidelines. He presented three months later with altered level of consciousness in the setting of diabetic ketoacidosis. He also had gastrointestinal bleed and cerebrovascular accident. There was a strong possibility of reinfection in this patient as he was tested negative after the initial infection and then tested positive three months later, presenting with a different set of symptoms and more severe disease on his second admission.
- 22 June 2021
- Published by Springer Nature in Cureus
- Vol. 13 (6) , e15825
Open AccessRe-Positive SARS-CoV-2 With Respiratory Failure and Cerebrovascular Accident: Is This a Reinfection?
The coronavirus disease 2019 ( COVID-19) pandemic is a global pandemic where healthcare providers are concerned about the reinfection of recovered patients. The reinfection with COVID-19 is not common and considered less likely, but as time passes by, there are reports of patients becoming positive after having tested negative previously. Here, we report a case of a 28-year-old male with diabetes mellitus type 1, hypertension, and end-stage renal disease on hemodialysis who presented initially in April 2020 with nausea, vomiting, and dyspnea. His severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) came back positive. He left against medical advice but was followed as an outpatient in the dialysis unit where he continued with dialysis in isolation for positive COVID-19 as per the dialysis unit guidelines. He presented three months later with altered level of consciousness in the setting of diabetic ketoacidosis. He also had gastrointestinal bleed and cerebrovascular accident. There was a strong possibility of reinfection in this patient as he was tested negative after the initial infection and then tested positive three months later, presenting with a different set of symptoms and more severe disease on his second admission.